Challenges and opportunities for China entering global research and development for emerging infectious diseases: a case study from Ebola experience
Abstract Background China has emerged as a powerful platform for global pharmaceutical research and development (R&D) amid the 2014 Ebola outbreak. The research and development impact of developing countries on prevention and control of infectious disease outbreaks has long been underestimated,...
Main Authors: | Chao Li, Jing-Yi Chen, Yang-Mu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Infectious Diseases of Poverty |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40249-020-00643-0 |
Similar Items
-
Ebola… How far away are we?
by: Salim Mattar V., et al.
Published: (2014-09-01) -
Operational Research during the Ebola Emergency
by: Gabriel Fitzpatrick, et al.
Published: (2017-07-01) -
Ebola virus disease and the search for a cure
by: André Kalil
Published: (2015-07-01) -
Ebola virus disease and the search for a cure
by: André Kalil
Published: (2015-07-01) -
The forgotten plague: Psychiatric manifestations of ebola, zika, and emerging infectious diseases
by: Veronica Tucci, et al.
Published: (2017-01-01)